Browsing Tag
Inc.
196 posts
Rigel Pharmaceuticals’ R289 delivers promising phase 1b results in transfusion-dependent MDS
Find out how Rigel Pharmaceuticals, Inc. is advancing R289 for lower-risk myelodysplastic syndrome with promising new phase 1b data—read the latest insights now!
Post Holdings exits pasta, Richardson scales U.S. food chain: What’s next for both firms?
Post Holdings sells 8th Avenue’s pasta unit to Richardson for $375M. Learn how this reshapes their food portfolios and what analysts expect next.
Why HeartBeam’s 510(k) appeal could reshape cardiac software approval timelines
HeartBeam outlines a dual-track regulatory strategy after FDA setback on ECG software. See how it plans to unlock clearance and stay on track for market entry.
Can MACOM’s new COO role help it handle global chip demand and supply chain risk?
Find out how MACOM Technology Solutions is strengthening operations by promoting Robert Dennehy to COO and what this signals about its global scale-up strategy.
Waymo vs Zoox: Who’s winning the battle for America’s autonomous taxi future?
Zoox launches free rides in San Francisco and scales production. Can it really catch up to Waymo’s multi-city robotaxi dominance? Find out more.
Premier (NASDAQ: PINC) stockholders approve $2.6bn buyout by Patient Square Capital, closing set for November 25
Premier stockholders approve $2.6B sale to Patient Square Capital. Find out what this means for investors, healthcare tech, and future innovation.
CD388 in focus as Merck announces $9.2bn deal for Cidara Therapeutics (NASDAQ: CDTX)
Merck is acquiring Cidara Therapeutics for $9.2B to expand into long-acting antivirals. Find out what makes CD388 a potential flu game-changer.
RMTG and CELLGENIC unveil pre-loaded peptide pens — the next frontier in regenerative therapy
Find out how RMTG’s CELLGENIC is expanding into device-enabled regenerative therapy with its new peptide-pen line introduced at the Cancún global summit.
Supermicro (NASDAQ: SMCI) launches Blackwell-powered plug-and-play AI clusters
Super Micro Computer, Inc. unveils Blackwell-powered AI factory clusters for rapid enterprise deployment. Find out how SMCI is streamlining AI at scale.
Major oncology milestone as Organon and Henlius secure FDA approval for POHERDY, the first U.S. biosimilar to PERJETA
Find out how FDA approval of POHERDY, the first U.S. biosimilar to PERJETA, may transform HER2-positive breast cancer treatment costs and patient access.